We aim to provide solutions across the spectrum of cancer side effects.
Lily: Technology aimed at reducing hair loss caused by chemotherapy
Hair loss is one of the most difficult aspects of cancer treatment. Our aim is to build technology that enables patients to reduce their risk of hair loss in a portable way - meaning less time spent in the infusion chair.
Lilac: Aiming to reduce the onset of peripheral neuropathy
Peripheral neuropathy is one of the most common side effects of anti-cancer treatment, and often leads to treatment cessation. Our technology aims to reduce the the onset of peripheral nerve damage in patients undergoing chemotherapy treatment.
Pipeline: Changing the future of cancer care
We're researching conditions secondary to cancer care that impact patient quality of life - like lymphedema, early onset menopause and post-treatment fertility issues.
WHO WE ARE
We build powerful healthcare technology with a commitment to being people first.
5 things to bring to your first chemo session
It's only natural that you would have questions and maybe even worries prior to your first chemotherapy treatment. Your care team will discuss your chemotherapy plan...
Luminate Medical Raises $5M Seed Round
Luminate Medical, an Irish startup developing devices to eliminate hair loss during chemotherapy announced that it has raised more than...
Shape the face of cancer treatment with a career at Luminate.
We design and build products that empower cancer patients. If you're a creative problem-solver, apply for one of our open roles.